DUBLIN–(BUSINESS WIRE)–The “North America Active Pharmaceutical Ingredients (API) Market 2021-2027 by Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Country: Trend Forecast and Growth Opportunity” report has been added to ResearchAndMarkets.com’s offering.
The North American active pharmaceutical ingredients (API) market is expected to grow by 5.5% annually in the forecast period and reach $106.28 billion by 2027 owing to the rising need for medicine and pharmaceutical agents amid the COVID-19 pandemic.
In-depth qualitative analyses include identification and investigation of the following aspects:
- Market Structure
- Growth Drivers
- Restraints and Challenges
- Emerging Product Trends & Market Opportunities
- Porter’s Five Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America API market in every aspect of the classification from perspectives of Synthesis, Manufacturing Process, Therapeutic Application, Drug Type, and Country.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in North America API market are assayed quantitatively and qualitatively through a Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players:
- AbbVie Inc.
- Astrazeneca
- Aurobindo Pharma Ltd.
- BASF
- Bayer AG
- Boehringer Ingelheim
- Dr. Reddy’s Laboratories
- F. Hoffmann-La Roche
- GlaxoSmithKline plc
- Lonza Group
- Lupin Limited
- Merck & Co., Inc.
- Mylan NV
- Novartis International AG
- Pfizer Inc.
- Sanofi
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
Key Topics Covered:
1 Introduction
2 Market Overview and Dynamics
3 Segmentation of North America Market by Synthesis
3.1 Market Overview by Synthesis
3.2 Synthetic API
3.3 Biotech API
3.4 HPAPI
4 Segmentation of North America Market by Manufacturing Process
4.1 Market Overview by Manufacturing Process
4.2 Captive Manufacturing
4.3 Merchant Manufacturing
5 Segmentation of North America Market by Therapeutic Application
5.1 Market Overview by Therapeutic Application
5.2 Infectious Diseases
5.3 Oncology
5.4 Ophthalmology
5.5 Cardiovascular Disorders
5.6 Central Nervous System
5.7 Pulmonary Disorders
5.8 Orthopedics
5.9 Other Applications
6 Segmentation of North America Market by Drug Type
7 North America Market 2020-2027 by Country
8 Competitive Landscape
8.1 Overview of Key Vendors
8.2 New Product Launch, Partnership, Investment, and M&A
8.3 Company Profiles
9 Investing in North America Market: Risk Assessment and Management
9.1 Risk Evaluation of North America Market
9.2 Critical Success Factors (CSFs)
Companies Mentioned
- AbbVie Inc.
- Astrazeneca
- Aurobindo Pharma Ltd.
- BASF
- Bayer AG
- Boehringer Ingelheim
- Dr. Reddy’s Laboratories
- F. Hoffmann-La Roche
- GlaxoSmithKline plc
- Lonza Group
- Lupin Limited
- Merck & Co., Inc.
- Mylan NV
- Novartis International AG
- Pfizer Inc.
- Sanofi
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/sznbv9
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900